POZEN Inc. (POZN) Announces Addition to Its Marketing and Sales Management Team

QualityStocks would like to highlight POZEN Inc. (NASDAQ: POZN), a progressive pharmaceutical company that is transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and a focus on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years - something almost no other small pharmaceutical company has done.

In the company’s news yesterday,

POZEN announced the appointment of Mark N. Matthews as vice-president of marketing and sales. Mr. Matthews will be responsible for driving the commercial strategy of all pipeline products. Prior to joining POZEN, Mr. Matthews held several key commercial positions, including vice-president of marketing and sales for Javelin Pharmaceuticals and vice-president of neurology marketing for Biogen Idec.

Mobile and digital communications are changing the way healthcare professionals and patients receive health information. POZEN plans to take advantage of these trends as a core driver of its business model. Mr. Matthews shares POZEN’s philosophy regarding the way new medicines are marketed and is well versed in the use of digital media.

Mr. Matthews’ efforts will begin with POZEN’s lead product candidate, PA32540, a coordinated-delivery tablet of enteric-coated aspirin and immediate-release omeprazole. This novel, patented oral product is currently in Phase 3 clinical development in the US, with New Drug Application (NDA) submission scheduled for 2012. This product is the first in a portfolio of aspirin therapies that POZEN is developing which are designed to enable the full power of aspirin by reducing its negative effects on some patients’ gastrointestinal tract.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.